Literature DB >> 8751212

The predictive value of serum laminin for the risk of variceal bleeding related to portal pressure levels.

M Kondo1, S J Miszputen, M M Leite-mor, E R Parise.   

Abstract

BACKGROUND/AIMS: This paper presents the results of the radioimmunologic determination of laminin in serum of patients with alcoholic liver cirrhosis with a preserved hepatic function, trying to evaluate its predictive value for the risk of variceal bleeding, assessed by a portal pressure level equal to or higher than 12 mmHg. PATIENTS AND METHODS: Twenty alcoholic cirrhotic patients with a preserved hepatic function as assessed by the Child-Pugh classification, had their peripheral blood taken for radioimmunological determination of serum laminin and were submitted to hepatic vein catheterization for portal pressure measurement.
RESULTS: A positive and significant correlation (r = 0.70, p < 0.001) was found between serum laminin levels (mean value + SD = 2.70 + 1.13 U/ml) and hepatic vein pressure gradient (mean HVPG + SD = 16.30 + 6.06 mmHg). Such correlation prompted us to find a value for the level of laminin that more closely represented a HVPG of 12 mmHg, a well known threshold pressure for esophageal varices bleeding. At a cut-off concentration for laminin of 2.19 U/ml, sensitivity was 73%, specificity 60%, the positive predictive value was 85% and the negative predictive value 43%. In this study population, with a prevalence of 75% of a HVPG > or = 12 mmHg, the diagnostic accuracy for such levels of serum laminin was 70%.
CONCLUSIONS: Although a valid attempt in having a non invasive parameter for the investigation of portal hypertension, peripheral serum laminin alone doesn't seem to be a reliable marker for predicting portal hypertension and to assess the risk of variceal bleeding in patients with alcoholic cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8751212

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  8 in total

Review 1.  Invasive and non-invasive diagnosis of cirrhosis and portal hypertension.

Authors:  Moon Young Kim; Woo Kyoung Jeong; Soon Koo Baik
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

2.  Higher pretherapy and significant decrease during the first 12 months of therapy in serum laminin levels may associate with hepatitis B e antigen seroconversion in chronic hepatitis B patients treated with lamivudine.

Authors:  Qunying Han; Sai Lou; Zhengwen Liu; Ni Zhang; Guoyu Zhang; Yi Lv; Shaoqiong Duan; Zhu Li
Journal:  Clin Exp Med       Date:  2010-02-05       Impact factor: 3.984

Review 3.  Is there a place for serum laminin determination in patients with liver disease and cancer?

Authors:  Heitor Rosa; Edison Roberto Parise
Journal:  World J Gastroenterol       Date:  2008-06-21       Impact factor: 5.742

4.  Noninvasive evaluation of portal hypertension: emerging tools and techniques.

Authors:  V K Snowdon; N Guha; J A Fallowfield
Journal:  Int J Hepatol       Date:  2012-06-07

Review 5.  Noninvasive Assessment of Portal Hypertension in Advanced Chronic Liver Disease: An Update.

Authors:  Federico Ravaioli; Marco Montagnani; Andrea Lisotti; Davide Festi; Giuseppe Mazzella; Francesco Azzaroli
Journal:  Gastroenterol Res Pract       Date:  2018-06-07       Impact factor: 2.260

Review 6.  Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches.

Authors:  Eirini Martinou; Marinos Pericleous; Irena Stefanova; Vasha Kaur; Angeliki M Angelidi
Journal:  Diagnostics (Basel)       Date:  2022-02-04

7.  Novel serological neo-epitope markers of extracellular matrix proteins for the detection of portal hypertension.

Authors:  D J Leeming; M A Karsdal; I Byrjalsen; F Bendtsen; J Trebicka; M J Nielsen; C Christiansen; S Møller; A Krag
Journal:  Aliment Pharmacol Ther       Date:  2013-09-15       Impact factor: 8.171

8.  Serum Liver Fibrosis Markers for Predicting the Presence of Gastroesophageal Varices in Liver Cirrhosis: A Retrospective Cross-Sectional Study.

Authors:  Xingshun Qi; Hongyu Li; Jiang Chen; Chunlian Xia; Ying Peng; Junna Dai; Yue Hou; Han Deng; Jing Li; Xiaozhong Guo
Journal:  Gastroenterol Res Pract       Date:  2015-12-06       Impact factor: 2.260

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.